Market Access News | pharmaphorum

News

House Oversight Committee chair James Comer (r)

PBMs will face House committee grilling next week

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next week, amid scrutiny of the sector's role in rising healthcare cos

News

NHS on course to use digital tech to diagnose ADHD

A digital test that will help to provide a faster diagnosis for people with attention deficit hyperactivity disorder (ADHD) should be used by the NHS, according to draft guidance from NICE.

News

Germany inches closer to confidential pricing for drugs

Pharma companies who want to keep the prices of their medicines private in Germany may soon be able to do so – as long as they meet certain conditions.

News

Proposed Medicare codes could lift digital health sector

A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the dig

News

Bill that would cut down ‘patent thickets’ clears Senate

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.

News

FDA rejects Novo Nordisk’s weekly basal insulin

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US.

PBMs will face House committee grilling next week

NHS on course to use digital tech to diagnose ADHD

Germany inches closer to confidential pricing for drugs

Proposed Medicare codes could lift digital health sector

Bill that would cut down ‘patent thickets’ clears Senate

FDA rejects Novo Nordisk’s weekly basal insulin

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks